• Medientyp: E-Artikel
  • Titel: DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity
  • Beteiligte: Kureshi, Rakeeb; Bello, Elisa; Kureshi, Courtney T.S.; Walsh, Michael J.; Lippert, Victoria; Hoffman, Megan T.; Dougan, Michael; Longmire, Tyler; Wichroski, Michael; Dougan, Stephanie K.
  • Erschienen: American Association for the Advancement of Science (AAAS), 2023
  • Erschienen in: Science Advances, 9 (2023) 47
  • Sprache: Englisch
  • DOI: 10.1126/sciadv.adk1853
  • ISSN: 2375-2548
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Diacylglycerol kinases (DGKs) attenuate diacylglycerol (DAG) signaling by converting DAG to phosphatidic acid, thereby suppressing pathways downstream of T cell receptor signaling. Using a dual DGKα/ζ inhibitor (DGKi), tumor-specific CD8 T cells with different affinities (TRP1 high and TRP1 low ), and altered peptide ligands, we demonstrate that inhibition of DGKα/ζ can lower the signaling threshold for T cell priming. TRP1 high and TRP1 low CD8 T cells produced more effector cytokines in the presence of cognate antigen and DGKi. Effector TRP1 high - and TRP1 low -mediated cytolysis of tumor cells with low antigen load required antigen recognition, was mediated by interferon-γ, and augmented by DGKi. Adoptive T cell transfer into mice bearing pancreatic or melanoma tumors synergized with single-agent DGKi or DGKi and antiprogrammed cell death protein 1 (PD-1), with increased expansion of low-affinity T cells and increased cytokine production observed in tumors of treated mice. Collectively, our findings highlight DGKα/ζ as therapeutic targets for augmenting tumor-specific CD8 T cell function.
  • Zugangsstatus: Freier Zugang